Clinical course of type 1 diabetes {#S0001}
==================================

Since the first therapeutic use of insulin the clinical course of type 1 diabetes (T1DM) has changed dramatically from a disease with very short life expectancy to a chronic condition, the course of which is influenced largely by the development of chronic complications.

The clinical onset of T1DM is preceded by a preclinical phase of variable duration, characterized by progressive autoimmune destruction of beta cells and presence of specific autoantibodies. In genetically susceptible individuals, this autoimmune reaction seems to be initiated and modulated by exposure to various environmental triggers and regulators, which might include viral infections or introducing cow\'s milk or cereals into the diet \[[@CIT0001]\]. According to the accelerator hypothesis \[[@CIT0002]\], an increased rate of β-cell apoptosis and insulin resistance modulate the timing of clinical onset and subsequent course of autoimmune diabetes. However, the autoimmune process is thought to be the main accelerator of β-cell destruction both before and after onset of T1DM \[[@CIT0003]\].

Clinical manifestation of T1DM varies considerably in severity with greater insulin deficiency and greater risk of diabetic ketoacidosis (DKA) in children and adolescents than in adults \[[@CIT0004]\]. After introduction of insulin treatment, many patients enter clinical remission of the disease with partially restored endogenous insulin secretion and near-normoglycemia on very low doses of exogenous insulin. In many patients with phenotypic T1DM residual insulin secretion can be maintained for over 30 years, and is associated with better metabolic control, including decreased incidence of both hyper- and hypoglycemia, and decreased risk of chronic complications when compared with patients without detectable insulin secretion \[[@CIT0005]\]. In the DCCT/EDIC (Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications) cohort, good initial metabolic control had a protective effect against chronic complications even despite subsequent deterioration in glycemic control \[[@CIT0006]\]. Chronic complications of T1DM typically do not occur before 5 years from the disease onset, with the highest risk of their early development in patients with diabetes diagnosed in puberty. Progression of microvascular complications leads to decreased quality of life and increased risk of macrovascular disease \[[@CIT0007]\]. Cardiovascular complications are the main cause of death in patients with T1DM. In the FinnDiane study, the 7-year mortality in patients with T1DM was three times higher than in the general population, although the difference disappeared after excluding patients with nephropathy \[[@CIT0008]\].

To describe quantitatively the efficacy of interventions on the course of diabetes many endpoints are used. The hard endpoints include: time of the disease onset (in prevention trials), onset and progression of microvascular complications (e.g. development of end-stage renal failure or proliferative retinopathy), acute hyperglycemic states, episodes of hypoglycemia, cardiovascular events, and mortality. The surrogate endpoints and other commonly used outcomes that characterize the course of diabetes may include: parameters of metabolic control, occurrence and duration of clinical remission, measures of residual insulin secretion, exogenous insulin dose, insulin sensitivity, and quality of life.

The clinical course of T1DM depends on a number of factors, including genetic background \[[@CIT0009]\], metabolic control (control of glycemia, lipid profile, blood pressure, body weight), treatment regimen used, physical activity, patient knowledge about diabetes, psychosocial factors and concomitant diseases. It is clear that many of these factors interact with lifestyle, and the lifestyle of a patient may in many ways influence the clinical course of T1DM.

To prepare this narrative review we searched the PubMed database using keywords describing lifestyle parameters (lifestyle, nutrition, diet, exercise, training, sport, physical activity, fitness, smoking, sleep, stress, socioeconomic, income, education) and diabetes-related outcomes (mortality, complications, cardiovascular, macroangiopathy, microangiopathy, retinopathy, nephropathy, neuropathy, glyc(a)emic control, glycated hemoglobin (HbA~1c~), glycated h(a)emoglobin, lipid profile, cholesterol, triglyceride, blood pressure, remission, insulin secretion, insulin requirement, insulin dose, insulin resistance). We confined the search to papers where patients with T1DM (searched also using the keyword insulin-dependent diabetes mellitus) were the only investigated group or one of the subgroups with separately presented outcomes. Papers where the type of diabetes was not specified were excluded. The studies conducted in patients with T1DM which are discussed in this review are summarized in [Table I](#T0001){ref-type="table"}.

###### 

Lifestyle parameters and diabetes-related outcomes. Summary of reviewed studies

  Ref.             First author, publication date   Intervention or exposure                                  Study design             *N* (cases/controls)   Main outcome(s)
  ---------------- -------------------------------- --------------------------------------------------------- ------------------------ ---------------------- --------------------------------------------------------------------------
  \[[@CIT0015]\]   Moy, 1993                        Overall physical activity level                           OP                       548                    Mortality
  \[[@CIT0018]\]   Zinman, 1984                     Aerobic exercise                                          CT                       13/7                   Glycemia, HbA~1c~
  \[[@CIT0019]\]   Durak, 1990                      Progressive resistance training                           RCT, crossover           8                      HbA~1c~, lipid profile, muscle strength
  \[[@CIT0020]\]   Laaksonen, 2000                  Aerobic exercise                                          RCT                      28/28                  Lipid profile
  \[[@CIT0021]\]   Tonoli, 2012                     Aerobic and/or resistance training                        Meta-analysis            33 studies^1^          HbA~1c~, glycemia
  \[[@CIT0025]\]   Rigla, 2000                      Aerobic and resistance training                           Self-controlled          14                     Lipid profile, BMI, VO~2~max
  \[[@CIT0026]\]   Mosher, 1998                     Aerobic exercise                                          CT                       10/10                  HbA~1c~, fasting glycemia, lipid profile, muscle strength
  \[[@CIT0027]\]   Kaplan, 1997                     Aerobic exercise                                          Self-controlled          20                     Lipid profile, BP, body fat, VO~2~max
  \[[@CIT0029]\]   LaPorte, 1986                    Various types of exercise                                 Case-control             696                    Chronic complications of diabetes, mortality
  \[[@CIT0031]\]   Chen, 2008                       Various types of exercise                                 C-S                      93/107                 Heart-rate variability
  \[[@CIT0033]\]   Yki-Jarvinen, 1984               Aerobic exercise                                          CT                       7/6                    Glucose disposal rate, insulin requirement, HbA~1c~, lipid profile
  \[[@CIT0036]\]   Seeger, 2011                     Aerobic exercise                                          Self-controlled          7                      Vascular function (flow-mediated dilation)
  \[[@CIT0037]\]   Fuchsjager-Mayrl, 2002           Aerobic exercise                                          CT                       18/8                   Vascular function (flow-mediated dilation, fundus pulsation amplitude)
  \[[@CIT0040]\]   Zoppini, 2003                    Various types of exercise                                 C-S                      30/23                  Quality of life
  \[[@CIT0048]\]   Buyken, 2001                     Glycemic index of diet                                    C-S                      2810                   HbA~1c~, lipid profile
  \[[@CIT0049]\]   Bortsov, 2011                    Sugar-sweetened and diet beverage intake                  C-S                      1806                   HbA~1c~, lipid profile
  \[[@CIT0050]\]   Nansel, 2012                     Diet quality and glycemic index                           C-S                      252                    HbA~1c~, BMI
  \[[@CIT0052]\]   Delahanty, 2009                  Macronutrient composition                                 RCT                      532                    HbA~1c~, lipid profile, BMI
  \[[@CIT0053]\]   Snell-Bergeon, 2009              Macronutrient composition                                 C-S                      571/696                Coronary artery calcium, coronary heart disease risk factors
  \[[@CIT0055]\]   Strychar, 2009                   Macronutrient composition                                 RCT                      30 (15/15)             BMI, BP, HbA~1c~, lipid profile, serum plasminogen activator inhibitor-1
  \[[@CIT0060]\]   Matheus, 2011                    Serum uric acid concentration                             C-S                      57/53                  Microvascular endothelial function (laser Doppler perfusion monitoring)
  \[[@CIT0073]\]   Moy, 1990                        Cigarette smoking                                         OP                       548                    Mortality
  \[[@CIT0074]\]   Chiodera, 1997                   Cigarette smoking                                         CT                       10/10                  Growth hormone, vasopressin, and cortisol concentrations
  \[[@CIT0078]\]   Pilacinski, 2012                 Cigarette smoking                                         OP                       149                    Duration of partial remission, HbA~1c~
  \[[@CIT0079]\]   Haire-Joshu, 1994                Cigarette smoking                                         C-S                      186 (83/103)           Symptoms of depression
  \[[@CIT0081]\]   Sawicki, 1994                    Cigarette smoking                                         OP                       93                     Progression of diabetic nephropathy
  \[[@CIT0082]\]   Muhlhauser, 1996                 Cigarette smoking                                         OP                       636                    Onset or progression of diabetic retinopathy or nephropathy
  \[[@CIT0083]\]   Mitchell, 1990                   Cigarette smoking                                         Case-control             163                    Prevalence of diabetic neuropathy
  \[[@CIT0086]\]   Lloyd, 1999                      Stressful life events                                     Case-control             55                     HbA~1c~
  \[[@CIT0087]\]   Wiesli, 2005                     Psychological stress -- Trier Social Stress Test (TSST)   CT                       40                     Glycemia
  \[[@CIT0088]\]   Riazi, 2004                      Daily stress                                              OP                       54                     Glycemia, HbA~1c~
  \[[@CIT0091]\]   Donga, 2010                      Sleep restriction                                         Self-controlled          7                      Glucose disposal rate
  \[[@CIT0092]\]   Borel, 2009                      Sleep duration                                            C-S                      20                     Blood pressure dipping status
  \[[@CIT0093]\]   van Dijk, 2011                   Sleep quality                                             C-S                      99                     HbA~1c~, symptoms of depression
  \[[@CIT0094]\]   Perfect, 2012                    Sleep architecture                                        CT (external controls)   40/40                  HbA~1c~, glycemia, QOL
  \[[@CIT0095]\]   Secrest, 2011                    Socioeconomic status                                      OP                       317                    Chronic complications of diabetes
  \[[@CIT0097]\]   Zgibor, 2000                     General/specialist care, education level, income          OP                       429                    HbA~1c~

Ref. -- reference number, RCT -- randomized controlled trial, CT -- controlled trial (not randomized), OP -- prospective observational study, C-S -- cross-sectional study; ^1^number of studies varied between analyses (studies with different types of exercises were analyzed separately)

Definition of lifestyle {#S0002}
=======================

Lifestyle is defined (according to the Thesaurus of Psychological Index Terms \[[@CIT0010]\]) as a "typical way of life or manner of living characteristic of an individual or group" and is influenced by socioeconomic, educational, and cultural factors. The lifestyle is closely related with the health behavior, defined as behaviors expressed by individuals to protect, maintain or promote their health status. In the World Health Organization\'s Health Promotion Glossary \[[@CIT0011]\] the lifestyle is defined as a "way of living based on identifiable patterns of behaviour which are determined by the interplay between an individual\'s personal characteristics, social interactions, and socioeconomic and environmental living conditions". The parameters most commonly analyzed in the assessment of lifestyle interventions include physical activity and nutrition. Other parameters that were taken into account include socioeconomic level, exposure to emotional stress, sleep duration, and specific unhealthy behaviors, including smoking, excessive alcohol intake and illicit drug use.

In the influence of a patient\'s lifestyle on the course of T1DM there is an important role for an appropriate treatment regimen. For the majority of patients with T1DM, the treatment of choice is intensive insulin therapy with pen injections or personal pumps, with dose adjustment based on glycemia, macronutrient (at least carbohydrate) content of the meals and planned physical activity. In the DCCT/EDIC cohort, intensive insulin treatment was effective in the prevention of chronic complications of diabetes \[[@CIT0012]\]. Allowing high flexibility in dietary choices and meal planning, as well as safe practice of physical activity, the flexible intensive insulin treatment interferes little with a patient\'s lifestyle and has the potential of achieving the best possible outcome.

Physical activity {#S0003}
=================

The beneficial effects of physical activity in the general population are numerous and include, apart from enhancement of well-being, decreased risk of cardiovascular and all-cause mortality, hypertension, obesity, dyslipidemia, type 2 diabetes (T2DM), osteoporosis, and cancer \[[@CIT0013]\]. Some of these effects were also documented in patients with T2DM, but the body of evidence for T1DM is limited \[[@CIT0014]\]. Therefore, many recommendations on physical activity for patients with T1DM are based on conclusions driven from studies on patients with T2DM or on healthy individuals.

Patients with T1DM undertake lower than advised levels of physical activity, but these levels are similar to nondiabetic subjects \[[@CIT0015]\]. The sedentary lifestyle and increased time spent watching television or using a computer was associated with poor glycemic control in young patients with T1DM \[[@CIT0016]\]. However, the beneficial impact of physical activity on glycemic control of T1DM is less documented than for patients with T2DM \[[@CIT0017]\]. Some studies have demonstrated the improvement in HbA~1c~ after supervised or unsupervised physical activity \[[@CIT0018], [@CIT0019]\], while other studies showed no benefit \[[@CIT0020]\]. The possible explanation of the lack of improvement in glycemic control may be increased energy consumption and reduced insulin dose associated with increased activity, and, very likely, lack of incorporation of exercise into a structured lifestyle modification plan, introduced along with relevant patient education \[[@CIT0018]\]. The influence of physical activity on glycemic control may also depend on the form of exercise training. The results of a recent meta-analysis demonstrate that only regular aerobic exercise training programs significantly improved acute and chronic glycemic control \[[@CIT0021]\]. Interestingly, addition of brief bouts of high-intensity exercise to aerobic exercise may decrease the risk of late hypoglycemic episodes occurring after training \[[@CIT0021]\]. In the studies that demonstrated a positive effect of exercise on glycemic control the decrease in HbA~1c~ was not associated with a significant increase in episodes of hypoglycemia. Decreased insulin requirement is commonly associated with increased physical activity and may be explained mainly by increased insulin-independent glucose uptake by myocytes and increased peripheral insulin sensitivity \[[@CIT0022]\]. Physical activity is effective in treatment of dyslipidemia in the general population \[[@CIT0023]\]. The majority of studies in subjects with T1DM support the beneficial effect of physical exercise on lipid levels, which is similar to the nondiabetic population and independent of glycemia and weight reduction. In subjects with T1DM, physical activity is particularly effective in increasing the serum high-density lipoprotein (HDL)-cholesterol concentration, but it also significantly decreased low-density lipoprotein (LDL)-cholesterol and triglycerides \[[@CIT0024]--[@CIT0026]\]. Physical activity was also found to reduce the apolipoprotein B concentration and increase the protective apolipoprotein A1 in patients with T1DM \[[@CIT0020]\].

There is limited evidence on the beneficial effect of physical exercise on blood pressure specifically in patients with T1DM. Some studies showed a small (\< 5%) improvement \[[@CIT0027]\] and other not \[[@CIT0028]\], possibly due to insufficient power to detect a difference in a small sample of young, predominantly normotensive patients.

The effect of physical activity on the hard endpoints in the course of T1DM appears to be beneficial. The Pittsburgh IDDM (insulin-dependent diabetes mellitus) Morbidity and Mortality Study showed that male patients who had practiced team sports in their teens had decreased risk of macroangiopathy and all-cause mortality 25 years after diagnosis than those less physically active \[[@CIT0029]\]. In women from this study the practice of team sports was nearly 2 times lower than in men, which might result in insufficient power to detect the benefit. The favorable effect on survival remained during 7-year follow-up of this group; however, again only in men, among whom sedentary subjects (overall activity level less than 1000 kcal/week) had three times increased mortality when compared with active males (above 2000 kcal/week) \[[@CIT0015]\]. The same study provided evidence of a protective effect of physical activity on the development of diabetic nephropathy and neuropathy in men. The main weakness of this large study was its retrospective cohort design and subjective assessment of past physical activity. In the FinnDiane study presence of chronic complications was associated with reduced physical activity \[[@CIT0030]\]. This may be largely because of the exercise-limiting effect of chronic complications, but the lower degree of albuminuria in patients reporting physical activity seems to be a causal relationship. Physical activity may also have a favorable effect on cardiovascular autonomic regulation in patients with T1DM, increasing heart rate variability \[[@CIT0031]\], spontaneous baroreflex gain and low-frequency oscillation in arterial pressure \[[@CIT0032]\].

Physical exercise increases insulin sensitivity in patients with T1DM \[[@CIT0033]\], which may have an impact on the course of the disease. Insulin resistance is common in T1DM and associated with increased risk of its chronic complications \[[@CIT0034]\]. In patients with diabetes physical activity may decrease oxidative stress \[[@CIT0035]\] and reverse endothelial dysfunction \[[@CIT0036], [@CIT0037]\], and these effects may also contribute to the increased insulin sensitivity. Available evidence suggests the positive effect of physical activity on β-cell function in patients with T2DM \[[@CIT0038]\] and overweight nondiabetic subjects \[[@CIT0039]\], but it was not directly investigated in patients with T1DM. Physical activity also improves quality of life (QOL) and well-being in patients with T1DM, a condition generally associated with lower QOL and increased prevalence of depression \[[@CIT0040]\].

Professional practice of competitive sports may have a different effect on health than leisure physical activity. Competitive sports are safe for people with T1DM if they have good metabolic control and are well educated about their disease and its interaction with physical exercise. However, aiming to improve performance and to achieve competitive success, some subjects may be involved in unhealthy practices that also have an adverse effect on metabolic control of diabetes \[[@CIT0041]\]. These practices may include specific dietary patterns with excessive intake of single macronutrients, e.g. protein, use of nutritional supplements or illegal substances. Particular vigilance for early identification of disordered eating is needed in women with T1DM practicing esthetic disciplines and some endurance sports, including distance running or swimming, which are associated with increased risk of these disorders \[[@CIT0041]\]. Some athletes with T1DM who practice sports with weight categories may omit insulin doses prior to weighing, which results in marked hyperglycemia, osmotic diuresis and rapid weight loss.

Nutrition {#S0004}
=========

Nutrition seems to modulate the course of T1DM from its early preclinical stages. Absence or short duration of breastfeeding and early introduction of cow\'s milk formulae are thought to be risk factors for the disease \[[@CIT0042]\]. Also rapid weight gain in infancy, associated with improper feeding, increases the risk of developing T1DM \[[@CIT0043]\]. Analyzing the influence of diet as a lifestyle component on the course of T1DM, several aspects of nutrition may be taken into account, including macro- and micronutrient content, daily meal regimen, effect of food on glycemia and other metabolic parameters, and adjustment of insulin treatment to the timing and content of meals.

According to the current treatment approach, the diet recommended to patients with T1DM in general does not differ from a healthy diet suggested for the general population. This enables individualized dietary advice that interferes little with a patient\'s lifestyle. The restrictions on consistent day-to-day carbohydrate content of the meals might be an important consideration where premixed insulin or fixed basal-bolus treatment is used. In these treatment regimens day-to-day variations of carbohydrate content were associated with elevated HbA~1c~ level \[[@CIT0044]\]. Patients who adjust insulin doses to the carbohydrate content of the meals do not need such restrictions to achieve adequate control of glycemia \[[@CIT0045]\]. The Dose Adjustment for Normal Eating (DAFNE) trial examined the value of flexible intensive insulin treatment with dietary freedom and carbohydrate counting, accompanied by a structured education program based on principles developed by a team from Dusseldorf \[[@CIT0046]\]. In the intervention group of this trial, not only a significant decrease in HbA~1c~ value, but also better QOL, general wellbeing and treatment satisfaction were noted compared with the control group subjects, who started learning the method 6 months later \[[@CIT0047]\]. Contrarily to the major concern of the DCCT, intensified treatment in the DAFNE trial did not increase the prevalence of hypoglycemia.

According to the above evidence, flexible meal pattern and content do not have a negative impact on the course and outcomes of T1DM in an educated patient using the appropriate treatment regimen. However, some diet choices may have a negative effect on parameters of metabolic control of the disease and, as a consequence, may result in increased risk of complications. These improper dietary habits include especially frequent consumption of food and beverages with a high glycemic index (GI) or diet low in carbohydrates and rich in saturated fat. Despite the fact that products with a high glycemic index are not strictly forbidden for patients with T1DM, especially those using flexible intensive insulin treatment, a rapid rise of postprandial glycemia following these meals is difficult to control even using rapid acting insulin analogues. Patients with T1DM who often consume meals with a high GI have poorly controlled postprandial glycemia, increased HbA~1c~ value, and decreased serum HDL-cholesterol concentration \[[@CIT0048]\]. Frequent intake of high-GI snacks, especially by children and adolescents, leads to obesity, dyslipidemia and poor glycemic control \[[@CIT0049]--[@CIT0051]\]. Interestingly, frequent consumption of diet beverages is associated with poor metabolic control of T1DM similarly to consumption of sweetened beverages, possibly being a marker of an unhealthy diet pattern \[[@CIT0049]\]. An adverse effect of a high-GI diet on the atherogenic risk profile is a significant finding in patients with T1DM, as atherosclerotic cardiovascular diseases are a major cause of increased mortality in this group. On the other hand, patients must be advised not to increase the saturated fat intake when introducing the low-GI diet. This was one of the causes of increased fat intake in the DCCT cohort. In the intensively treated patients of this trial, saturated fat equaled nearly 13% of total caloric intake and diets higher in total and saturated fat and lower in carbohydrate were associated with worse glycemic control independent of exercise and body mass index (BMI) \[[@CIT0052]\]. The other cause of increased fat intake in some patients with T1DM may be low-carbohydrate nutrition used in an effort to minimize the need for insulin injections or to lose weight. As a consequence, people with T1DM consume a diet with higher fat and saturated fat content than recommended and even higher than members of the general population \[[@CIT0053], [@CIT0054]\]. Meanwhile, carbohydrate intake may be partially substituted with sources of monounsaturated fat, which would reduce the glycemic index of the diet without an atherogenic effect \[[@CIT0055]\].

Many young people with T1DM present a lifestyle associated with low attention to dietary choices and frequent consumption of fast food. Apart from other negative effects, this diet is usually associated with very high intake of food rich in trans-unsaturated fatty acids (from hydrogenated vegetable oils) and food additives, such as monosodium glutamate. Dietary trans fatty acids are associated with adverse cardiometabolic effects: increased low-grade inflammation, insulin resistance and accelerated atherosclerosis \[[@CIT0056]\].

Consumption of sodium glutamate was associated with development of insulin resistance, T2DM and liver steatosis in animal models \[[@CIT0057]\], but these effects were not investigated in humans. Consumption of a high purine diet or diet rich in fructose or sucrose contributes to hyperuricemia, which may play a pathogenic role in the metabolic syndrome and increase cardiovascular risk \[[@CIT0058], [@CIT0059]\]. Hyperuricemia may be associated with microvascular endothelial dysfunction in T1DM \[[@CIT0060]\] and diabetic nephropathy \[[@CIT0058]\].

Vitamins, including antioxidant E and C, and mineral supplements are not routinely recommended in T1DM \[[@CIT0061]\] but their use among patients is very common \[[@CIT0062]\]. The evidence on the supplementation of vitamin D in T1DM is also insufficient, despite its possible favorable effects on oxidative stress, insulin resistance and autoimmunity \[[@CIT0063]\].

Eating disorders are more common in T1DM than in the nondiabetic population \[[@CIT0064]\]. While they are not lifestyles but clinical entities, behaviors not satisfying diagnostic criteria of a particular eating disorder are also common in T1DM \[[@CIT0065]\]. Disordered eating is associated with poor compliance and metabolic control and decreased survival in T1DM \[[@CIT0066]\] with increased risk of both DKA and chronic complications of the disease. Binge eating disorder was found to be associated with the practice of insulin omission in women with T1DM \[[@CIT0067]\].

Alcohol and illicit drugs intake {#S0005}
================================

In patients with T1DM alcohol consumption may cause hypoglycemia mainly due to gluconeogenesis inhibition. Alcohol intake may also result in neglecting diabetes self-care -- not measuring glycemia, omitting insulin doses and also involvement in risky behavior \[[@CIT0068], [@CIT0069]\]. These have an adverse influence on metabolic control and the course of disease, including glycemic instability and increased risk of DKA \[[@CIT0070]\]. It is worth noting that moderate consumption of wine is not prohibited, and may have beneficial vascular effects in diabetes \[[@CIT0071]\].

The data on illicit drug use among patients with T1DM are sparse, but the clinical observations confirm its deleterious effect on the course of the disease, severely compromising the patient\'s self-care practices \[[@CIT0072]\].

Smoking {#S0006}
=======

Cigarette smoking adversely influences health, and the risk increases considerably when added to the risk conferred by diabetes. During 6-year observation of a T1DM cohort, Moy *et al*. \[[@CIT0073]\] reported over 2.5 times increased risk of death in female smokers compared with nonsmokers, which was explained mainly by increased cardiovascular mortality. Hormonal responses to cigarette smoking, including growth hormone, cortisol and vasopressin, are counter-regulatory to insulin \[[@CIT0074]\] and may lead to insulin resistance \[[@CIT0075]\]. Nicotine may also directly inhibit insulin secretion \[[@CIT0076]\]. Patients with T1DM who smoke were found to have higher HbA~1c~ values than non-smoking subjects \[[@CIT0077]\] and experience shorter partial remission \[[@CIT0078]\]. Moreover, diabetic patients who smoke report less confidence in health care professionals, are more likely to report symptoms of depression, and may be less compliant to treatment \[[@CIT0079]\]. Apart from accelerated atherosclerosis \[[@CIT0080]\], smoking is associated with increased risk of microangiopathic complications in T1DM. This relationship is well documented for diabetic nephropathy and neuropathy, and very likely for retinopathy. Sawicki *et al*. \[[@CIT0081]\] reported that over 1 year of observation, progression of nephropathy was less common in nonsmokers (11%) than in smokers (53%) and in past smokers (33%). In another study \[[@CIT0082]\] during 6-year observation, the odds of progression of nephropathy increased by 27% for each 10 pack years. In a study by Mitchell *et al*. \[[@CIT0083]\] patients smoking 30 pack years or more were 3.32 times more likely to have neuropathy than those smoking less than this amount.

Psychological stress {#S0007}
====================

Stressful life events, such as losses within the family, were found to be associated with increased risk of development of T1DM in children, especially in the age group of 5--9 years \[[@CIT0084]\], but also older ones \[[@CIT0085]\]. These events occurred mainly during the second year preceding the diagnosis of T1DM and may be considered as possible triggering factors that precipitate or accelerate the autoimmune process. In patients with established T1DM, psychological stress may be associated with poor glycemic control \[[@CIT0086]\]. The causality of this relationship is supported by a study in which acute psychosocial stress was associated with subsequent hyperglycemia \[[@CIT0087]\]. Of note, marked individual differences occur in the blood glucose response to stress, and in many subjects the reactivity may be weak or undetectable \[[@CIT0088]\].

Sleep duration {#S0008}
==============

The influence of sleep duration on glycemic control of T1DM is unknown. However, partial sleep restriction decreased glucose tolerance in healthy subjects \[[@CIT0089]\] and induced insulin resistance in both healthy subjects \[[@CIT0090]\] and in patients with T1DM \[[@CIT0091]\]. In patients with T1DM short sleep duration may also be associated with the blood pressure nondipping pattern \[[@CIT0092]\]. Patients with a long history of T1DM have poor subjective sleep quality and are at increased risk for obstructive sleep apnea \[[@CIT0093]\] compared with nondiabetic controls. Sleep-disordered breathing is associated with poor metabolic control and decreased quality of life \[[@CIT0094]\].

Socioeconomic status {#S0009}
====================

The association between socioeconomic status and the course of T1DM was analyzed in the Pittsburgh Epidemiology of Diabetes Complication Study. Lower education was associated with increased prevalence of end-stage renal disease and coronary artery disease, and lower income was associated with autonomic neuropathy and peripheral arterial disease \[[@CIT0095]\]. Higher educational level was also found to be associated with lower mortality in T1DM \[[@CIT0096]\]. These associations, although independent of sex and diabetes duration, may be partly mediated by poorer management of diabetes and presence of risk factors for chronic complications. Lower family income was associated with worse glycemic control in adult and adolescent patients with T1DM \[[@CIT0097]\]. On the other hand, higher socioeconomic status and higher degree of urbanization are associated with increased incidence and prevalence of T1DM \[[@CIT0098]\].

Conclusions {#S0010}
===========

Although lifestyle seems to modify the course of T1DM in many ways, the evidence on these relationships appears to be very incomplete. The largest body of evidence was accumulated on the influence of nutrition, physical activity and smoking on diabetes-related outcomes; however, many questions remain, including those already answered for T2DM. Other lifestyle parameters have rarely been analyzed in patients with T1DM.

This necessitates further research, especially including the assessment of the efficacy of lifestyle interventions on the course of T1DM.
